PHARMACOKINETICS OF N-PROPYLAJMALINE IN RELATION TO POLYMORPHIC SPARTEINE OXIDATION

被引：38
作者：
ZEKORN, C
ACHTERT, G
HAUSLEITER, HJ
MOON, CH
EICHELBAUM, M
机构：
[1] UNIV BONN,MED KLIN,D-5300 BONN,FED REP GER
[2] KALI CHEM AG,SPARTA PHARMA,BIOCHEM ABT,HANNOVER,FED REP GER
来源：
KLINISCHE WOCHENSCHRIFT | 1985年 / 63卷 / 22期
关键词：
D O I：
10.1007/BF01740595
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1180 / 1186
页数：7
相关论文
共 24 条
[1]   ORALLY-ADMINISTERED PRAJMALIUM BITARTRATE IN ACUTE AND CHRONIC VENTRICULAR ARRHYTHMIAS [J].
BUSSMANN, WD ;
MULLER, E ;
HANEL, HJ ;
KALTENBACH, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (03) :577-583
[2]   STERIC CONFIGURATION AND POLYMORPHIC OXIDATION OF LIPOPHILIC BETA-ADRENOCEPTOR BLOCKING-AGENTS - INVIVO INVITRO CORRELATIONS [J].
DAYER, P ;
LEEMANN, T ;
GUT, J ;
KRONBACH, T ;
KUPFER, A ;
FRANCIS, R ;
MEYER, UA .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (03) :399-400
[3]   INTERINDIVIDUAL VARIATION OF BETA-ADRENOCEPTOR BLOCKING-DRUGS, PLASMA-CONCENTRATION AND EFFECT - INFLUENCE OF GENETIC STATUS ON BEHAVIOR OF ATENOLOL, BOPINDOLOL AND METOPROLOL [J].
DAYER, P ;
LEEMANN, T ;
MARMY, A ;
ROSENTHALER, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (02) :149-153
[4]  
DENGLER HJ, 1977, ARZNEIMITTEL-FORSCH, V27-2, P1836
[5]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[6]  
EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[7]  
EICHELBAUM M, 1978, BIOL OXIDATION NITRO, P113
[8]  
EICHELBAUM M, 1984, FED PROC, V43, P98
[9]  
FRANCIS RJ, 1983, EUR J CLIN PHARM, V23, P529
[10]  
HAUSLEITER HJ, 1982, EUR J DRUG METAB PH, V7, P329, DOI 10.1007/BF03189637
123